Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 2/20 | 0.62 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.62 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.62 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.62 |
| ▸ | LDHA | P00338 | 1/20 | 0.62 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.62 |
| ▸ | FBP1 | P09467 | 1/20 | 0.62 |
| ▸ | SRC | P12931 | 1/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.62 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.62 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.62 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.62 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.62 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.62 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.62 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.62 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20225019 | 1.00 | P2RY1 (0.62) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL18837728 | 1.00 | P2RY1 (0.62) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL20959779 | 1.00 | P2RY1 (0.62) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL20225051 | 1.00 | P2RY1 (0.62) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL19145744 | 0.93 | POLB (0.54) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL23978230 | 0.92 | P2RX3 (0.61) | P2RY1TRPM2SRCP2RY2SMN1; SMN2 | |
| SCHEMBL31229395 | 0.92 | P2RX3 (0.61) | P2RY1TRPM2SRCP2RY2SMN1; SMN2 | |
| SCHEMBL4969963 | 0.92 | P2RX3 (0.61) | P2RY1TRPM2SRCP2RY2SMN1; SMN2 | |
| SCHEMBL21894145 | 0.92 | BCHE (0.53) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL21636992 | 0.92 | POLB (0.53) | P2RY1DNPH1PRKAB2TRPM2LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4285463-B1 | WIRELESS POWER TRANSMISSION SYSTEMS AND METHODS FOR SELECTIVELY SIGNAL DAMPING FOR ENHANCED COMMUNICATIONS FIDELITY | NUCURRENT INC (US) | 2025-12-17 | — | — | EP | claimed |
| CN-116191616-B | Wireless charging and discharging adjusting equipment suitable for welding production line | 淮阴工学院 | 2023-10-20 | — | — | CN | claimed |
| CN-116191616-A | Wireless charging and discharging adjusting equipment suitable for welding production line | 淮阴工学院 | 2023-05-30 | — | — | CN | claimed |
| CN-115438842-A | Load prediction method based on adaptive improved dayflies and BP neural network | 武汉大学 | 2022-12-06 | — | — | CN | claimed |
| WO-2014031954-A1 | HOMOPOLYMER MEDIATED NUCLEIC ACID AMPLIFICATION | TUFTS UNIVERSITY (US) | 2014-02-27 | — | — | WO | claimed |
| EP-2428201-A1 | Oral administration of nucleoside monophosphates | Merck Serono S.A. (CH) | 2012-03-14 | — | — | EP | claimed |
| US-6498036-B1 | Methods of targeting a chromosomal gene sequence in a eukaryotic cell | TRUSTEES OF AMHERST COLLEGE | 2002-12-24 | — | — | US | claimed |
| US-5627165-A | ANTIVIRAL AND ANTILEUKEMIA AGENTS | DRUG INNOVATION & DESIGN, INC. (US) | 1997-05-06 | — | — | US | claimed |
| EP-0533833-B1 | PHOSPHOROUS PRODUGS | GLAZIER ARNOLD (US) | 1995-12-20 | — | — | EP | claimed |
| EP-0533833-A1 | PHOSPHOROUS PRODRUGS. | GLAZIER ARNOLD (US) | 1993-03-31 | — | — | EP | claimed |
| WO-1991019721-A1 | PHOSPHOROUS PRODUGS | GLAZIER ARNOLD (US) | 1991-12-26 | — | — | WO | claimed |
| US-20260142690-A1 | Wireless Power Transfer System With Data Versus Power Priority Optimization | NUCURRENT INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12634614-B2 | Wireless power transfer system for wearable communication devices | NUCURRENT, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-12633782-B2 | Software based thermal mitigation for wireless power and data transfer systems | NUCURRENT, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| WO-2026098934-A1 | AUXILIARY DEVICE FOR CONTROLLING AN ENGINE WITH ELECTROMAGNETICALLY CONTROLLED INJECTORS | FR TEAM INTERNATIONAL S.A. (LU) | 2026-05-15 | — | — | WO | disclosed |
| EP-0355135-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-02-28 | — | — | EP | disclosed |
| EP-0350287-A2 | Lipid derivatives of antiviral nucleosides, liposomal incorporation and method of use | NeXstar Pharmaceuticals, Inc. (US) | 1990-01-10 | — | — | EP | disclosed |
| WO-1989004662-A1 | ADENOSINE DEAMINASE-STABLE ANTI-RETROVIRAL NUCLEOSIDES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-06-01 | — | — | WO | disclosed |
| US-4788181-A | 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1988-11-29 | — | — | US | disclosed |
| EP-0284405-A2 | Anti-viral compounds, dosage forms and methods | BAKER NORTON PHARMACEUTICALS, INC. (US) | 1988-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12633782-B2 | Software based thermal mitigation for wireless power and data transfer systems | CRY2, CHRNA2, TRHDE | P2RY1 2224/4885DNPH1 3285/4885PRKAB2 56/4885 |
| US-12634614-B2 | Wireless power transfer system for wearable communication devices | WAPL, ATRIP, ADIPOR1 | P2RY1 562/4885DNPH1 4420/4885PRKAB2 173/4885 |
| US-20260142690-A1 | Wireless Power Transfer System With Data Versus Power Priority Optimization | USE1, SLC18A2, AADAT | P2RY1 1610/4885DNPH1 3953/4885PRKAB2 2983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.